Anne Worsoe

just closed an #angelinvestment in a 🇳🇴 tech #startup. Everyone involved (incl. founders & team) = 28 ppl, that's 27 men and one woman - me. 🤔 Yep, there's still work to do. #InternationalWomensDay

DNC airs new “Freedom” ad to kick off the Democratic Convention

well-deserved shout-out from @Finansavisen to @SafetyWing CEO @SRasch & the team! 🙌 finansavisen.no/teknologi/2024…

🙌 Awesome news: eif.org/what_we_do/equ…

This is priceless 🌴🥥 😂💃💪 #KamalaHarris2024 #brat

Is Europe even relevant anymore? -Or is it only good for Harry Potter, the Louvre and fancy cheese?  Let's take a whimsical jaunt through things that Europe still does quite well… And where it might stand to improve.

"Be kind whenever possible. It is always possible." Dalai Lama 🙏

Oh #Europe 🇪🇺

Well-deserved shout-out for an amazing team 🤩 & @AntlerGlobal alumni! Spoor uses AI to save birds from wind turbines techcrunch.com/2024/05/16/spo… via @techcrunch #biodiversity #AI #angelinvestor

Thanks for a super inspiring event 🙏

Love it 🤩 - congrats to the brilliant @sanity_io team! 🙌

Godt jobbet @NRKno - sånn vil vi ikke ha det: nrk.no/dokumentar/xl/…

While biotech has been challenging, there’s still much to be thankful for - esp the great bio community dedicated to “doing well by doing good” bringing Rx's to patients. Feel so very fortunate to work in this industry. Wishes of health, happiness, and gratitude for Thanksgiving.

#HappyThanksgiving 🙏

Det er ca 1 : 5.400.000 sjanse for å vinne i Lotto. Hvis risikoen ved å investere i #biotech aksjer hadde vært i nærheten av like høy som å spille Lotto, ville det neppe eksistert medisinsk fremskritt i verden 😄🔬#justsaying

@ProfessorLOLca7 @ultimovacs That’s an excellent question for the webcast; I’ll send it to Professor Helland! Thanks 😄🙏

@shewrote @ultimovacs Thank you for clarifying! And congratulations again to the team. How has the feedback been thus far in Madrid?

Our updated Company Presentation includes data from the randomized Phase II study NIPU presented at #ESMO23 today. The webcast Mon 14:30 will be streamed, link on our website. Questions can be sent during the webcast or to IR@ultimovacs.com 💫 ultimovacs.com/investors/pres…

@ProfessorLOLca7 @ultimovacs Yes, but we decided to publish it Mon morning 07:00 to reach a larger audience and incl the webcast presentation. The key data is incl in the Com Prez though, the webcast is primarily for context and Q&A.

@ultimovacs «The full dataset will be shared in a *separate press release* and at the Company website after the Principal Investigator's oral presentation,Saturday October 21, 2023 at 15:15 (CET)» Ref. ** Will you release a separate press release as well?

@HellandAslaug presenting the first patient survival data from the NIPU trial at #ESMO2023

@Ultimovacs Rebounds on New Universal Cancer Vaccine Data for #Mesothelioma | BioSpace #biotech #immunotherapy biospace.com/article/ultimo…

@KristianFalnes @ultimovacs @HellandAslaug 🙌

@ultimovacs Mange gratulasjoner til Åslaug og team @ultimovacs

Ultimovacs Announces NIPU Results Presented at ESMO 2023: Significant and Clinically Meaningful Improvement in Overall Survival for Patients Receiving UV1 Cancer Vaccine in Phase II NIPU Trial in Malignant Mesothelioma bit.ly/3QiYABc